BCAX
Price
$23.17
Change
-$0.00 (-0.00%)
Updated
Sep 8, 12:20 PM (EDT)
Capitalization
1.53B
70 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$29.22
Change
-$0.44 (-1.48%)
Updated
Sep 8, 12:35 PM (EDT)
Capitalization
3.78B
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCAX vs RCUS

BCAX vs RCUS Comparison Chart in %
View a ticker or compare two or three
VS
BCAX vs. RCUS commentary
Sep 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCAX is a Hold and RCUS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2026
Stock price -- (BCAX: $23.17 vs. RCUS: $29.66)
Brand notoriety: BCAX and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCAX: 46% vs. RCUS: 67%
Market capitalization -- BCAX: $1.53B vs. RCUS: $3.78B
BCAX [@Biotechnology] is valued at $1.53B. RCUS’s [@Biotechnology] market capitalization is $3.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCAX’s FA Score shows that 1 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • BCAX’s FA Score: 1 green, 4 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, BCAX is a better buy in the long-term than RCUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCAX’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • BCAX’s TA Score: 3 bullish, 5 bearish.
  • RCUS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RCUS is a better buy in the short-term than BCAX.

Price Growth

BCAX (@Biotechnology) experienced а -1.11% price change this week, while RCUS (@Biotechnology) price change was +1.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

BCAX is expected to report earnings on Nov 17, 2026.

RCUS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($3.78B) has a higher market cap than BCAX($1.53B). BCAX YTD gains are higher at: 37.671 vs. RCUS (24.465). BCAX has higher annual earnings (EBITDA): -201.83M vs. RCUS (-439M). RCUS has more cash in the bank: 702M vs. BCAX (497M). BCAX has less debt than RCUS: BCAX (1.16M) vs RCUS (114M). RCUS has higher revenues than BCAX: RCUS (117M) vs BCAX (0).
BCAXRCUSBCAX / RCUS
Capitalization1.53B3.78B41%
EBITDA-201.83M-439M46%
Gain YTD37.67124.465154%
P/E Ratio3.41N/A-
Revenue0117M-
Total Cash497M702M71%
Total Debt1.16M114M1%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCAXRCUS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
90%
Bullish Trend 5 days ago
87%
Momentum
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 5 days ago
73%
MACD
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
86%
Bullish Trend 5 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
77%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 12 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 5 days ago
78%
Aroon
ODDS (%)
Bearish Trend 5 days ago
73%
Bullish Trend 5 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BCAX
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ITDH43.460.03
+0.06%
iShares LifePath Target Date 2060 ETF
YMAR29.450.02
+0.05%
FT Vest Intl Eq Mod Bffr ETF Mar
DXUV69.91-0.05
-0.07%
Dimensional US Vector Equity ETF
GPIX56.04-0.14
-0.25%
Goldman Sachs S&P 500 Premium Inc ETF
IND23.12-0.07
-0.30%
Xtrackers Nifty 500 India ETF

BCAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCAX has been loosely correlated with CLDX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BCAX jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCAX
1D Price
Change %
BCAX100%
-0.73%
CLDX - BCAX
44%
Loosely correlated
+0.79%
BCYC - BCAX
44%
Loosely correlated
+1.42%
RCUS - BCAX
43%
Loosely correlated
-1.56%
PCVX - BCAX
43%
Loosely correlated
-0.02%
VKTX - BCAX
42%
Loosely correlated
+2.62%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with VIR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
-1.56%
VIR - RCUS
49%
Loosely correlated
-0.57%
XNCR - RCUS
49%
Loosely correlated
-0.04%
DYN - RCUS
46%
Loosely correlated
-2.69%
AURA - RCUS
44%
Loosely correlated
+2.58%
KURA - RCUS
44%
Loosely correlated
+0.76%
More